The landscape of dementia diagnosis has evolved significantly with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which can detect Alzheimer's pathology several years prior to symptoms emerge. While these technological advancements symbolize remarkable progress in understanding neurodegenerative disorders, they've not di... https://anatolee208grb9.wikihearsay.com/user